These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 9168493

  • 1. [Current medical therapies for Crohn's disease in Japan].
    Munakata A, Haga Y.
    Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):406-11. PubMed ID: 9168493
    [Abstract] [Full Text] [Related]

  • 2. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Sandborn WJ, Feagan BG, Lichtenstein GR.
    Aliment Pharmacol Ther; 2007 Oct 01; 26(7):987-1003. PubMed ID: 17877506
    [Abstract] [Full Text] [Related]

  • 3. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA.
    Aliment Pharmacol Ther; 2004 Oct 01; 20 Suppl 4():102-5. PubMed ID: 15352904
    [Abstract] [Full Text] [Related]

  • 4. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG, Sandborn WJ.
    Rev Gastroenterol Disord; 2002 Oct 01; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [Abstract] [Full Text] [Related]

  • 5. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
    Sutherland LR.
    CMAJ; 1987 Nov 01; 137(9):799-802. PubMed ID: 2894889
    [Abstract] [Full Text] [Related]

  • 6. Current treatment modalities in active Crohn's disease.
    Biancone L, Pallone F.
    Ital J Gastroenterol Hepatol; 1999 Nov 01; 31(6):508-14. PubMed ID: 10575571
    [Abstract] [Full Text] [Related]

  • 7. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA.
    Neth J Med; 1994 Aug 01; 45(2):55-9. PubMed ID: 7936006
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G, Israel DM, Hassall E.
    Am J Gastroenterol; 1996 Jul 01; 91(7):1355-9. PubMed ID: 8677994
    [Abstract] [Full Text] [Related]

  • 9. Current treatment for prevention of relapse and recurrence in Crohn's disease.
    Prantera C, Scribano ML.
    Ital J Gastroenterol Hepatol; 1999 Jul 01; 31(6):515-8. PubMed ID: 10575572
    [Abstract] [Full Text] [Related]

  • 10. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun 01; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 11. [Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
    Schölmerich J, Gerok W.
    Wien Klin Wochenschr; 1986 Nov 21; 98(22):762-9. PubMed ID: 2880425
    [Abstract] [Full Text] [Related]

  • 12. Maintenance of symptomatic remission in patients with Crohn's disease.
    Stark ME, Tremaine WJ.
    Mayo Clin Proc; 1993 Dec 21; 68(12):1183-90. PubMed ID: 7902474
    [Abstract] [Full Text] [Related]

  • 13. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
    Steinhart AH, Hemphill D, Greenberg GR.
    Am J Gastroenterol; 1994 Dec 21; 89(12):2116-24. PubMed ID: 7977225
    [Abstract] [Full Text] [Related]

  • 14. Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators.
    Feagan BG, McDonald JW, Rochon J, Laupacis A, Fedorak RN, Kinnear D, Saibil F, Groll A, Archambault A, Gillies R.
    N Engl J Med; 1994 Jun 30; 330(26):1846-51. PubMed ID: 8196727
    [Abstract] [Full Text] [Related]

  • 15. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
    Hanauer SB, Krawitt EL, Robinson M, Rick GG, Safdi MA.
    Am J Gastroenterol; 1993 Sep 30; 88(9):1343-51. PubMed ID: 8362827
    [Abstract] [Full Text] [Related]

  • 16. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K, Fischer C, Klotz U, Heinkel K.
    Dtsch Med Wochenschr; 1982 Jul 23; 107(29-30):1131-4. PubMed ID: 6123426
    [Abstract] [Full Text] [Related]

  • 17. Review article: maintenance treatment of Crohn's disease.
    Biancone L, Tosti C, Fina D, Fantini M, De Nigris F, Geremia A, Pallone F.
    Aliment Pharmacol Ther; 2003 Jun 23; 17 Suppl 2():31-7. PubMed ID: 12786610
    [Abstract] [Full Text] [Related]

  • 18. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
    Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW.
    N Engl J Med; 2000 Jun 01; 342(22):1627-32. PubMed ID: 10833208
    [Abstract] [Full Text] [Related]

  • 19. Maintenance treatment for Crohn's disease: has the time arrived?
    Goldstein F.
    Am J Gastroenterol; 1992 May 01; 87(5):551-6. PubMed ID: 1350706
    [No Abstract] [Full Text] [Related]

  • 20. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA.
    Compr Ther; 1985 Dec 01; 11(12):14-9. PubMed ID: 2866866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.